Nega Woldehawariat, MD
Nephrology · Austell, GANPI 1437210358
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (52.8%), food and beverage and education — rather than concentrated in one kind of arrangement. Vantive US Healthcare LLC accounts for 68.8% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $1,019, more than ten times the $100 reported in 2019. That places this record below the midpoint for nephrology clinicians in GA, where the typical reported total is $1,554.
Across 16 payments — averaging $88.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vantive US Healthcare LLC$971
- AstraZeneca$236
- Amgen$116
- Bayer$28
- Novartis$20
- Aurinia Pharma U.S., Inc.$20
- plus $19 from 1 others
What the payments were for
- Travel & lodging$74553%
- Food & beverage$62744%
- Education$393%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vantive US Healthcare LLC | 6 | $971 |
| AstraZeneca | 3 | $236 |
| Amgen | 2 | $116 |
| Bayer | 2 | $28 |
| Novartis | 1 | $20 |
| Aurinia Pharma U.S., Inc. | 1 | $20 |
| OPKO Pharmaceuticals, LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Renal - Acute$870
- LOKELMA$121
How this compares
$1,411 in reported general payments places this provider in the 45th percentile of 388 nephrology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AuryxiaFerric Citrate | 30 | $69,613 |
| KerendiaFinerenone | 25 | $21,588 |
| FarxigaDapagliflozin Propanediol | 18 | $12,472 |
| LokelmaSodium Zirconium Cyclosilicate | 20 | $9,390 |
| Sevelamer Carbonate | 33 | $8,478 |
| ProsolParenteral Amino Acid 20% No.1 | 35 | $6,129 |
| Midodrine Hcl | 20 | $3,798 |
| Nifedipine ErNifedipine | 44 | $1,284 |
| Hydralazine Hcl | 43 | $847 |
| Potassium Chloride | 12 | $669 |
| Clonidine Hcl | 42 | $604 |
| Carvedilol | 51 | $455 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $423 |
| Torsemide | 28 | $350 |
| Lisinopril | 30 | $299 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Lokelma | $236 | $21,86238 claims |
| BayerKerendia | $28 | $21,58825 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 388 nephrology providers in Georgia.
Other nephrology in Austell
- Uno BarcelliAustell$12K
- Sagar PanseMacon$542K
- Sheldon ShoreAtlanta$474K
- James TumlinLawrenceville$434K
- Salvatore ChillemiMarietta$287K
- Christina KleinAtlanta$137K
- Mary MuonekeAtlanta$119K
- Don WilliamsonAugusta$104K
- Frederic Rahbari OskouiAtlanta$88K
- Rajendran AlappanColumbus$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.